These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21358463)

  • 1. Photodynamic therapy in highly myopic eyes with choroidal neovascularization: 5 years of follow-up.
    Coutinho AM; Silva RM; Nunes SG; Cachulo ML; Figueira JP; Murta JN
    Retina; 2011 Jun; 31(6):1089-94. PubMed ID: 21358463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.
    Maár N; Ergun E; Luksch A; Stur M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis.
    Varano M; Iacono P; Giorno P; Chiaravalloti A; Parravano M
    Ophthalmologica; 2014; 231(4):204-10. PubMed ID: 24481122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
    Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of photodynamic therapy for subfoveal choroidal neovascularization with pathologic myopia.
    Giansanti F; Virgili G; Donati MC; Giuntoli M; Pieretti G; Abbruzzese G; Menchini U
    Retina; 2012 Sep; 32(8):1547-52. PubMed ID: 22481476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
    Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization.
    Yoon JU; Byun YJ; Koh HJ
    Retina; 2010 Mar; 30(3):418-24. PubMed ID: 20094012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hara W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2008 Mar; 145(3):518-526. PubMed ID: 18207125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.
    Shaikh S; Ruby AJ; Williams GA
    Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia.
    Virgili G; Varano M; Giacomelli G; Arena MC; Tedeschi M; Pascarella A; Catalano S; Menchini U
    Am J Ophthalmol; 2007 Jan; 143(1):77-82. PubMed ID: 17188043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
    Ergun E; Heinzl H; Stur M
    Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Int Ophthalmol; 2012 Apr; 32(2):119-25. PubMed ID: 22350116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.